vimarsana.com

Page 267 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UnitedHealthcare Invests $11 1M To Address SDOH Needs

Patricia Baran, Author at MedCity News

Patricia Baran, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

To Optimize Health Outcomes, Home Medical Devices Must Operate Within Disease Management Programs

FDA Approves Blood Thinner Reversal Drug, But Requires More Tests to Assess Serious Risk

While Octapharma drug Balfaxar met the goal of its pivotal clinical trial, more deaths and blood clot problems were reported in the study drug arm versus the comparator group. The FDA is requiring a post-marketing study to further assess the drug’s risks.

FDA Refuses to Review Biohaven Drug for Rare Neuromuscular Disease With No Treatments

Biohaven’s bid to bring to market the first drug for rare neuromuscular disorder spinocerebellar ataxia has hit a setback. The FDA is refusing to review the drug’s application, a decision that could indicate the agency wants another clinical trial.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.